Immune Repertoire Profiling with DNBSEQ

Immune Repertoire Profiling with DNBSEQ

Immune Repertoire Profiling with DNBSEQ

Dr. Xiaojing Huo talks about the expansive domain of genomics and biomedical research, the ability to precisely sequence and interpret genetic material is a cornerstone of scientific advancement. As researchers endeavour to decode the intricate blueprints of DNA and RNA, state-of-the-art sequencing technologies such as the DNBSEQ-G99, T7, and G400 by MGI play a crucial role in empowering the intricate process of immune repertoire profiling.

Immunology

Pioneering Immune Repertoire Profiling

Immune repertoire profiling examines the array of T-cell receptors (TCR) and B-cell receptors (BCR) within an organism. This analysis is pivotal for understanding the immune system’s nuanced responses to pathogens and diseases.

Precision Profiling

Detailed TCR and BCR analysis, crucial for advancing understanding in immunology and oncology.

Expansive Scope

Capable of analyzing vast sections, offering a comprehensive view previously unattainable.

Spatial Resolution

Sub-cellular resolution ensures gene expression is captured without cross-contamination.

Stereo-Seq Technology

Bridging Genomic and Proteomic Worlds

MGI’s Stereo-Seq technology addresses the need for integrating genomic data with proteomic information within the same tissue sample.

01

High-Plex Panels

Antibody panels capture a broad spectrum of protein expressions for comprehensive analysis.

02

Innovative Capture

Utilizes poly-A tails and DNA barcodes to efficiently integrate RNA and protein data.

03

Data Integrity

Ensures reliability and reproducibility across various samples for robust biological models.

New Frontiers

Tissue Analysis

Cellular Subtype Mapping

Demonstrated power in distinguishing intricate cellular interactions and subtypes in human tissues.

Multiomic Integration

Combining genomic and proteomic data to unlock discoveries in therapeutic targeting.

MGI Sequencers

Genomic Exploration

Platform Versatility

The G99, T7, and G400 platforms facilitate breakthroughs in disease research and oncology.

State-of-the-Art Precision

Setting new standards in precision medicine through detailed molecular analysis.

Conclusion

The insights provided by the DNBSEQ technology, particularly through applications like immune repertoire profiling, are invaluable in the ongoing quest to understand and treat complex diseases. Equipped with MGI’s technology, researchers are heralding a new era of scientific discovery and medical breakthroughs, delving into molecular intricacies with unprecedented detail and scale.

Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended for use in diagnostic procedures. MGI products mentioned are for research use only.

Published 19 August 2021

Discover More